131 related articles for article (PubMed ID: 17080236)
1. Stromal osteonectin overexpression is associated with poor outcome in patients with ampullary cancer.
Bloomston M; Ellison EC; Muscarella P; Al-Saif O; Martin EW; Melvin WS; Frankel WL
Ann Surg Oncol; 2007 Jan; 14(1):211-7. PubMed ID: 17080236
[TBL] [Abstract][Full Text] [Related]
2. Predictors of failure after pancreaticoduodenectomy for ampullary carcinoma.
Kim RD; Kundhal PS; McGilvray ID; Cattral MS; Taylor B; Langer B; Grant DR; Zogopoulos G; Shah SA; Greig PD; Gallinger S
J Am Coll Surg; 2006 Jan; 202(1):112-9. PubMed ID: 16377504
[TBL] [Abstract][Full Text] [Related]
3. Cyclin D1 and bax influence the prognosis after pancreatoduodenectomy for periampullary adenocarcinoma.
Tomazic A; Pegan V; Ferlan-Marolt K; Pleskovic A; Luzar B
Hepatogastroenterology; 2004; 51(60):1832-7. PubMed ID: 15532837
[TBL] [Abstract][Full Text] [Related]
4. Tumor-related factors and patient's age influence survival after resection for ampullary adenocarcinoma.
Barauskas G; Gulbinas A; Pranys D; Dambrauskas Z; Pundzius J
J Hepatobiliary Pancreat Surg; 2008; 15(4):423-8. PubMed ID: 18670845
[TBL] [Abstract][Full Text] [Related]
5. Lack of CD44 variant 6 expression in advanced extrahepatic bile duct/ampullary carcinoma.
Yokoyama Y; Hiyama E; Murakami Y; Matsuura Y; Yokoyama T
Cancer; 1999 Nov; 86(9):1691-9. PubMed ID: 10547541
[TBL] [Abstract][Full Text] [Related]
6. A survival predictive model in patients undergoing radical resection of ampullary adenocarcinoma.
Wang CH; Mo LR; Lin RC; Kuo JJ; Chang KK; Lin YW; Yang DM; Yau MP; Cho CY
Hepatogastroenterology; 2004; 51(59):1495-9. PubMed ID: 15362785
[TBL] [Abstract][Full Text] [Related]
7. Tumors of the ampulla of vater: histopathologic classification and predictors of survival.
Carter JT; Grenert JP; Rubenstein L; Stewart L; Way LW
J Am Coll Surg; 2008 Aug; 207(2):210-8. PubMed ID: 18656049
[TBL] [Abstract][Full Text] [Related]
8. Mucins and CD56 as markers of tumour invasion and prognosis in periampullary cancer.
Aloysius MM; Zaitoun AM; Awad S; Ilyas M; Rowlands BJ; Lobo DN
Br J Surg; 2010 Aug; 97(8):1269-78. PubMed ID: 20602499
[TBL] [Abstract][Full Text] [Related]
9. Improved survival for adenocarcinoma of the ampulla of Vater: fifty-five consecutive resections.
Duffy JP; Hines OJ; Liu JH; Ko CY; Cortina G; Isacoff WH; Nguyen H; Leonardi M; Tompkins RK; Reber HA
Arch Surg; 2003 Sep; 138(9):941-8; discussion 948-50. PubMed ID: 12963649
[TBL] [Abstract][Full Text] [Related]
10. Important prognostic factors in adenocarcinoma of the ampulla of Vater.
Lowe MC; Coban I; Adsay NV; Sarmiento JM; Chu CK; Staley CA; Galloway JR; Kooby DA
Am Surg; 2009 Sep; 75(9):754-60; discussion 761. PubMed ID: 19774945
[TBL] [Abstract][Full Text] [Related]
11. Predictors for patterns of failure after pancreaticoduodenectomy in ampullary cancer.
Hsu HP; Yang TM; Hsieh YH; Shan YS; Lin PW
Ann Surg Oncol; 2007 Jan; 14(1):50-60. PubMed ID: 17054003
[TBL] [Abstract][Full Text] [Related]
12. Survival after resection of ampullary carcinoma: a national population-based study.
O'Connell JB; Maggard MA; Manunga J; Tomlinson JS; Reber HA; Ko CY; Hines OJ
Ann Surg Oncol; 2008 Jul; 15(7):1820-7. PubMed ID: 18369675
[TBL] [Abstract][Full Text] [Related]
13. Long-term results of surgical treatment of Vater's ampulla neoplasms.
Bucher P; Chassot G; Durmishi Y; Ris F; Morel P
Hepatogastroenterology; 2007 Jun; 54(76):1239-42. PubMed ID: 17629078
[TBL] [Abstract][Full Text] [Related]
14. Significant overexpression of SPARC/osteonectin mRNA in pancreatic cancer compared to cancer of the papilla of Vater.
Prenzel KL; Warnecke-Eberz U; Xi H; Brabender J; Baldus SE; Bollschweiler E; Gutschow CA; Hölscher AH; Schneider PM
Oncol Rep; 2006 May; 15(5):1397-401. PubMed ID: 16596217
[TBL] [Abstract][Full Text] [Related]
15. Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up.
Riall TS; Cameron JL; Lillemoe KD; Winter JM; Campbell KA; Hruban RH; Chang D; Yeo CJ
Surgery; 2006 Nov; 140(5):764-72. PubMed ID: 17084719
[TBL] [Abstract][Full Text] [Related]
16. Implications of histological grade of tumour for the prognosis of radically resected periampullary adenocarcinoma.
Sellner FJ; Riegler FM; Machacek E
Eur J Surg; 1999 Sep; 165(9):865-70. PubMed ID: 10533763
[TBL] [Abstract][Full Text] [Related]
17. Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor.
Westgaard A; Tafjord S; Farstad IN; Cvancarova M; Eide TJ; Mathisen O; Clausen OP; Gladhaug IP
BMC Cancer; 2008 Jan; 8():5. PubMed ID: 18194510
[TBL] [Abstract][Full Text] [Related]
18. Expression of MUC1 and MUC2 in ampullary cancer.
Moriya T; Kimura W; Hirai I; Takasu N; Mizutani M
Int J Surg Pathol; 2011 Aug; 19(4):441-7. PubMed ID: 21700631
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 overexpression is associated with a poor outcome in resected ampullary cancer patients.
Santini D; Vincenzi B; Tonini G; Scarpa S; Vasaturo F; Malacrino C; Vecchio F; Borzomati D; Valeri S; Coppola R; Magistrelli P; Nuzzo G; Picciocchi A
Clin Cancer Res; 2005 May; 11(10):3784-9. PubMed ID: 15897577
[TBL] [Abstract][Full Text] [Related]
20. Liver perfusion chemotherapy for selected patients at a high-risk of liver metastasis after resection of duodenal and ampullary cancers.
Noda T; Ohigashi H; Ishikawa O; Eguchi H; Yamada T; Sasaki Y; Yano M; Imaoka S
Ann Surg; 2007 Nov; 246(5):799-805. PubMed ID: 17968172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
